Follow
Berglind Osk Einarsdottir
Berglind Osk Einarsdottir
Post-doc
Verified email at hi.is
Title
Cited by
Cited by
Year
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ...
Nature 508 (7495), 215-221, 2014
5372014
Validation and development of MTH1 inhibitors for treatment of cancer
UW Berglund, K Sanjiv, H Gad, C Kalderen, T Koolmeister, T Pham, ...
Annals of oncology 27 (12), 2275-2283, 2016
1402016
BRAFV600 inhibition alters the microRNA cargo in the vesicular secretome of malignant melanoma cells
TR Lunavat, L Cheng, BO Einarsdottir, R Olofsson Bagge, ...
Proceedings of the National Academy of Sciences 114 (29), E5930-E5939, 2017
1222017
Molecular profiling of driver events in metastatic uveal melanoma
J Karlsson, LM Nilsson, S Mitra, S Alsén, GV Shelke, VR Sah, ...
Nature communications 11 (1), 1894, 2020
1182020
Melanoma patient-derived xenografts accurately model the disease and develop fast enough to guide treatment decisions
BO Einarsdottir, RO Bagge, J Bhadury, H Jespersen, J Mattsson, ...
Oncotarget 5 (20), 9609, 2014
732014
Hip fractures and bone mineral density in the elderly—importance of serum 25-hydroxyvitamin D
L Steingrimsdottir, TI Halldorsson, K Siggeirsdottir, MF Cotch, ...
PloS one 9 (3), e91122, 2014
552014
MITF reprograms the extracellular matrix and focal adhesion in melanoma
R Dilshat, V Fock, C Kenny, I Gerritsen, RMJ Lasseur, J Travnickova, ...
Elife 10, e63093, 2021
502021
High expression of ZNF703 independent of amplification indicates worse prognosis in patients with luminal B breast cancer
I Reynisdottir, A Arason, BO Einarsdottir, H Gunnarsson, J Staaf, ...
Cancer medicine 2 (4), 437-446, 2013
432013
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
BO Einarsdottir, J Karlsson, EMV Söderberg, MF Lindberg, ...
Cell Death & Disease 9 (8), 810, 2018
402018
BET bromodomain inhibitors synergize with ATR inhibitors in melanoma
SV Muralidharan, BO Einarsdottir, J Bhadury, MF Lindberg, J Wu, ...
Cell death & disease 8 (8), e2982-e2982, 2017
202017
Hypoxia-regulated gene expression explains differences between melanoma cell line-derived xenografts and patient-derived xenografts
J Bhadury, BO Einarsdottir, A Podraza, RO Bagge, U Stierner, L Ny, ...
Oncotarget 7 (17), 23801, 2016
122016
Cell-type-specific meQTLs extend melanoma GWAS annotation beyond eQTLs and inform melanocyte gene-regulatory mechanisms
T Zhang, J Choi, R Dilshat, BÓ Einarsdóttir, MA Kovacs, M Xu, M Malasky, ...
The American Journal of Human Genetics 108 (9), 1631-1646, 2021
112021
Mutational signature and transcriptomic classification analyses as the decisive diagnostic tools for a cancer of unknown primary
RO Bagge, A Demir, J Karlsson, B Alaei-Mahabadi, BO Einarsdottir, ...
JCO precision oncology 2, 1-25, 2018
112018
Correction: Corrigendum: MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ...
Nature 544 (7651), 508-508, 2017
52017
Molecular profiling of driver events and tumor-infiltrating lymphocytes in metastatic uveal melanoma
J Karlsson, LM Nilsson, EMV Forsberg, S Mitra, S Alsén, G Shelke, ...
bioRxiv, 742023, 2019
32019
Abstract B38: Melanoma patient-derived xenografts accurately models the disease and develop fast enough to guide treatment decisions
BO Einarsdottir, RO Bagge, J Bhadury, H Jespersen, LM Nilsson, ...
Cancer Research 75 (14_Supplement), B38-B38, 2015
12015
MITF reprograms the extracellular matrix and focal adhesion in melanoma
D Ramile, V Fock, C Kenny, G Ilse, LRM Jacques, T Jana, C Philipp, ...
eLife 10, 2021
2021
MITF Isoforms-Insights from an RNA-Seq study
K Kirty, S Sigurðsson, Þ Guðjónsson, B Ósk Einarsdóttir, S Sigurðsson
bioRxiv, 2020.10. 22.351031, 2020
2020
A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma (vol 9, 810, 2018)
BO Einarsdottir, J Karlsson, E Soderberg, MF Lindberg, E Funck-Brentano, ...
CELL DEATH & DISEASE 11 (2), 2020
2020
Correction: A patient-derived xenograft pre-clinical trial reveals treatment responses and a resistance mechanism to karonudib in metastatic melanoma
BO Einarsdottir, J Karlsson, EMV Söderberg, MF Lindberg, ...
Cell Death & Disease 11 (2), 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20